Study programme 2020-2021 | Français | ||
Technologie Pharmaceutique: galénique & biopharmacie | |||
Learning Activity |
Code | Lecturer(s) | Associate Lecturer(s) | Subsitute Lecturer(s) et other(s) | Establishment |
---|---|---|---|---|
M-DOYM-089 |
|
|
Language of instruction | Language of assessment | HT(*) | HTPE(*) | HTPS(*) | HR(*) | HD(*) | Term |
---|---|---|---|---|---|---|---|
Français | Français | 30 | 70 | 0 | 0 | 0 | Q2 |
Organisational online arrangements for the end of Q3 2020-2021 assessments (Covid-19) |
---|
|
Description of the modifications to the Q3 2020-2021 assessment procedures (Covid-19) |
The modalities of evaluation will be considered as follows: - oral theoretical presential exam = ponderation of 80% of the total note of the UE - already performed practical work (TP) = 20 % of the total note of the UE if and only if the note of the oral theoretical presential exam is superior to the mean (example: superior or equal 10/20 |
Organisational arrangements for the end of Q2 2020-2021 assessments (Covid-19) online or face-to-face (according to assessment schedule)
Description of the modifications to the Q2 2020-2021 assessment procedures (Covid-19) online or face-to-face (according to assessment schedule)
The modalities of evaluation will be considered as follows:
- oral theoretical presential exam = ponderation of 80% of the total note of the UE
- already performed practical work (TP) = 20 % of the total note of the UE if and only if the note of the oral theoretical presential exam is superior to the mean (example: superior or equal 10/20
Type of Teaching Activity/Activities
Evaluations
The assessment methods of the Learning Activity (AA) are specified in the course description of the corresponding Educational Component (UE)